Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | 1 | IL12(p40) | 62.0 | 27 | |||||||
| 0 | IL12(p40) | 65.0 | 56 | ||||||||
| 0 | IL12(p40) | 64.0 | 35 | ||||||||
| RA2159 | TNF-a | 100 | ng/mL | 1 | IL12(p40) | 65.0 | 60 | ||||
| RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | IL12(p40) | 68.0 | 50 | |
| RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL12(p40) | 66.0 | 59 | |
| RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL12(p40) | 63.5 | 56 | |
| RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL12(p40) | 74.0 | 63 | |
| RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | IL12(p40) | 58.0 | 49 | |
| RA2159 | EO1428 | 1.0 | uM | 1 | IL12(p40) | 60.0 | 68 | ||||
| N2586 | TNF-a | 100 | ng/mL | 1 | IL12(p40) | 70.5 | 42 | ||||
| N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | IL12(p40) | 76.0 | 39 | |
| N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL12(p40) | 58.0 | 41 | |
| N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL12(p40) | 66.0 | 78 | |
| N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL12(p40) | 67.5 | 64 | |
| N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | IL12(p40) | 60.0 | 34 | |
| N2586 | EO1428 | 1.0 | uM | 1 | IL12(p40) | 58.0 | 57 | ||||
| RA2159 | IL-1 alpha | 100 | ng/mL | 1 | IL12(p40) | 79.5 | 62 | ||||
| RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL12(p40) | 67.0 | 56 | |
| RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL12(p40) | 69.0 | 43 | |
| RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL12(p40) | 63.0 | 61 | |
| RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL12(p40) | 66.5 | 62 | |
| RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL12(p40) | 64.0 | 60 | |
| RA2159 | PI103 | 0.1 | uM | 1 | IL12(p40) | 66.0 | 56 | ||||
| N2586 | IL-1 alpha | 100 | ng/mL | 1 | IL12(p40) | 68.5 | 36 |